1. Home
  2. HUN vs BRVE Comparison

HUN vs BRVE Comparison

Compare HUN & BRVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

N/A

Current Price

$9.58

Market Cap

1.7B

Sector

Industrials

ML Signal

N/A

Logo Braveheart Bio Inc. Common Stock

BRVE

Braveheart Bio Inc. Common Stock

N/A

Current Price

$21.40

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUN
BRVE
Founded
1970
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2004
2026

Fundamental Metrics

Financial Performance
Metric
HUN
BRVE
Price
$9.58
$21.40
Analyst Decision
Hold
Strong Buy
Analyst Count
15
5
Target Price
$10.29
★ $45.25
AVG Volume (30 Days)
★ 2.8M
305.0K
Earning Date
11-02-2026
11-19-2026
Dividend Yield
★ 3.90%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $5,683,000,000.00
N/A
Revenue This Year
$8.36
N/A
Revenue Next Year
$2.01
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.30
$17.86
52 Week High
$16.09
$32.00

Technical Indicators

Market Signals
Indicator
HUN
BRVE
Relative Strength Index (RSI) 64.70 48.33
Support Level $9.42 $17.93
Resistance Level $9.99 $29.86
Average True Range (ATR) 0.37 1.25
MACD 0.15 0.43
Stochastic Oscillator 98.12 80.69

Price Performance

Historical Comparison
HUN
BRVE

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About BRVE Braveheart Bio Inc. Common Stock

Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).

Share on Social Networks: